Long-Term Outcome of Differentiated Thyroid Carcinoma: Experience in a Developing Country

被引:27
|
作者
Bhargav, Panchagan Rama Kant [1 ]
Mishra, Anjali [1 ]
Agarwal, Gaurav [1 ]
Agarwal, Amit [1 ]
Pradhan, Prasanta Kumar [2 ]
Gambhir, Sanjay [2 ]
Verma, Ashok Kumar [1 ]
Mishra, Saroj Kanta [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrine Surg, Lucknow 226014, Uttar Pradesh, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Nucl Med, Lucknow 226014, Uttar Pradesh, India
关键词
SURGICAL-TREATMENT; BONE METASTASES; CANCER; PAPILLARY; IMPACT; THERAPY; MICROCARCINOMA; FEATURES; PERIOD;
D O I
10.1007/s00268-009-0293-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
The presentation and outcome of differentiated thyroid carcinoma (DTC) in developing countries are different from the developed nations. We report the clinicopathologic profile and long-term outcome of DTC in an iodine-deficient area (IDA) in a developing country. This retrospective study included 302 patients with DTC operated between 1989 and 2002. These patients had been followed up for a minimum period of 5 years after surgery. Clinicopathological profile, intervention, and follow-up details were noted. Mean age of the patients was 42 +/- A 14 years. Mean follow-up period was 80 +/- A 34 (24-196) months. Papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), and poorly differentiated thyroid carcinoma (PDTC) was present in 62, 30, and 8% patients, respectively. Mean tumor size was 3.5 cm. Tumor multicentricity was noted in 40% of PTC, 22.2% of FTC, and 25% of PDTC patients. Lymphadenopathy was observed in 45, 10, and 67% patients with PTC, FTC, and PDTC, respectively. Extrathyroidal invasion and distant metastasis were observed in 36.8% (PTC 33%; FTC 36%; PDTC 71%) and 27% (PTC 17%; FTC 44%; PDTC 42%) of cases, respectively. Twenty percent of patients had synchronous metastases. Risk stratification ratio was 1:1.8 (high-risk vs. low-risk). Initial operative procedure was total thyroidectomy in 86.5% cases, and therapeutic lymph node dissection was performed in 37% cases. A total of 77.2% patients received adjuvant radioiodine therapy. Disease recurred in 26.6% of patients (thyroid bed recurrence 1.7%), and 21.2% patients died during follow-up. Overall survival (OS) rate at 10 years in both low-risk and high-risk groups of FTC (80 and 54%) was inferior to PTC (94 and 62%). Five-year OS for PDTC was 50%. Tumor multicentricity was a significant risk factor for OS in the low-risk group, whereas the presence of skeletal metastases and extrathyroidal invasion were significant factors for OS in the high-risk group. Advance stage at presentation and proportionately high rates of FTC and PDTC contribute to poor outcome of DTC in developing countries. Despite dismal outcome, total thyroidectomy seems to prevent thyroid bed recurrence in surviving patients.
引用
收藏
页码:40 / 47
页数:8
相关论文
共 50 条
  • [21] Clinico-pathological Characteristics and Long-term Outcome in Patients with Distant Metastases from Differentiated Thyroid Carcinoma
    Carlos A. Benbassat
    Sara Mechlis-Frish
    Dania Hirsch
    World Journal of Surgery, 2007, 31 : 247 - 248
  • [22] Clinico-Pathological Characteristics and Long-term Outcome in Patients with Distant Metastases from Differentiated Thyroid Carcinoma
    Vivek Aggarwal
    P. R. K. Bhargav
    Anjali Mishra
    Gaurav Agarwal
    World Journal of Surgery, 2007, 31 : 246 - 247
  • [23] Clinico-pathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid carcinoma
    Aggarwal, Vivek
    Bhargav, P. R. K.
    Mishra, Anjali
    Agarwal, Gaurav
    WORLD JOURNAL OF SURGERY, 2007, 31 (01) : 246 - 247
  • [24] Diastolic Dysfunction is Common in Long-Term Survivors of Paediatric Differentiated Thyroid Carcinoma
    Hesselink, M. Klein
    Bocca, G.
    Hummel, Y.
    Brouwers, A.
    Burgerhof, J.
    Van Dam, E.
    Gietema, J.
    Havekes, B.
    van den Heuvel-Eibrink, M.
    Corssmit, E.
    Kremer, L.
    Netea-Maier, R.
    van der Pal, H.
    Peeters, R.
    Plukker, J.
    Ronckers, C.
    Van Santen, H.
    van der Meer, P.
    Links, T.
    Tissing, W.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S242 - S242
  • [25] Long-term follow-up of differentiated thyroid carcinoma in children and adolescents
    Negre Buso, Montserrat
    Garcia Burillo, Amparo
    Simo Perdigo, Marc
    Galofre Mora, Pere
    Boronat de Ferrater, Maria
    Cuberas Borros, Gemma
    Sabado Alvarez, Constantino
    Castell Conesa, Joan
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (11): : 1431 - 1441
  • [26] LONG-TERM RESULTS AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA
    TUBIANA, M
    SCHLUMBERGER, M
    ROUGIER, P
    LAPLANCHE, A
    BENHAMOU, E
    GARDET, P
    CAILLOU, B
    TRAVAGLI, JP
    PARMENTIER, C
    CANCER, 1985, 55 (04) : 794 - 804
  • [27] Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma
    Nies, Marloes
    Hesselink, Marielle S. Klein
    Huizinga, Gea A.
    Sulkers, Esther
    Brouwers, Adrienne H.
    Burgerhof, Johannes G. M.
    van Dam, Eveline W. C. M.
    Havekes, Bas
    van den Heuvel-Eibrink, Marry M.
    Corssmit, Eleonora P. M.
    Kremer, Leontien C. M.
    Netea-Maier, Romana T.
    van der Pal, Heleen J. H.
    Peeters, Robin P.
    Plukker, John T. M.
    Ronckers, Cecile M.
    van Santen, Hanneke M.
    Tissing, Wim J. E.
    Links, Thera P.
    Bocca, Gianni
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (04): : 1218 - 1226
  • [28] Long-Term Cardiovascular Mortality in Patients With Differentiated Thyroid Carcinoma: An Observational Study
    Hesselink, Esther N. Klein
    Hesselink, Marielle S. Klein
    de Bock, Geertruida H.
    Gansevoort, Ron T.
    Bakker, Stephan J. L.
    Vredeveld, Eline J.
    van der Horst-Schrivers, Anouk N. A.
    van der Horst, Iwan C. C.
    Kamphuisen, Pieter W.
    Plukker, John T. M.
    Links, Thera P.
    Lefrandt, Joop D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) : 4046 - 4053
  • [29] Long-Term Follow-Up for Differentiated Thyroid Carcinoma Patients: A Reconsideration
    van der Wardt, Robin A. L.
    Persoon, Adrienne C. M.
    Hesselink, Esther N. Klein
    Links, Thera P.
    THYROID, 2017, 27 (03) : 475 - 476
  • [30] Outcome of 18f-Fluorodeoxyglucose Positron Emission Tomography (PET)-Directed Resections in Differentiated Thyroid Carcinoma (DTC): Experience in a Developing Country
    Chandan Kumar Jha
    Anjali Mishra
    Prasanta Kumar Pradhan
    Sanjay Gambhir
    Gaurav Agarwal
    Gyan Chand
    Amit Agarwal
    Saroj Kanta Mishra
    Indian Journal of Surgical Oncology, 2022, 13 : 23 - 27